Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease (Q40016546)

16 September 2017

Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease (English)

1 reference

16 September 2017

0 references

1 reference

Young Mook Lee

1

1 reference

16 September 2017

Seong H Park

2

1 reference

16 September 2017

Dong-Ik Shin

3

1 reference

16 September 2017

Jee-Yeon Hwang

4

1 reference

16 September 2017

Bokyung Park

5

1 reference

16 September 2017

Yun-Jong Park

6

1 reference

16 September 2017

Tae H Lee

7

1 reference

16 September 2017

Ho Z Chae

8

1 reference

16 September 2017

Byung K Jin

9

1 reference

16 September 2017

Tae H Oh

10

1 reference

16 September 2017

Young J Oh

11

1 reference

16 September 2017

language of work or name

English

0 references

publication date

4 February 2008

1 reference

Journal of Biological Chemistry

16 September 2017

1 reference

16 September 2017

283

1 reference

16 September 2017

15

1 reference

16 September 2017

9986-9998

1 reference

Parkinson's disease: mechanisms and models

16 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

The ubiquitin pathway in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Mitochondria, oxidants, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Molecular pathophysiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Brain Peroxidase and Catalase in Parkinson Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Glutathione peroxidase activity in Parkinson's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Glutathione peroxidase, glial cells and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Dopamine covalently modifies and functionally inactivates parkin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Oxidative modifications and aggregation of Cu,Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Phosphorylation of p38 MAPK induced by oxidative stress is linked to activation of both caspase-8- and -9-mediated apoptotic pathways in dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Growth of a rat neuroblastoma cell line in serum-free supplemented medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Reversible oxidation of the active site cysteine of peroxiredoxins to cysteine sulfinic acid. Immunoblot detection with antibodies specific for the hyperoxidized cysteine-containing sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Rapid identification of proteins by peptide-mass fingerprinting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Structure, mechanism and regulation of peroxiredoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Mouse peroxiredoxin V is a thioredoxin peroxidase that inhibits p53-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Augmented expression of peroxiredoxin I in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

An antisense oligonucleotide to 1-cys peroxiredoxin causes lipid peroxidation and apoptosis in lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Dual role of peroxiredoxin I in macrophage-derived foam cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Prx1 suppresses radiation-induced c-Jun NH2-terminal kinase signaling in lung cancer cells through interaction with the glutathione S-transferase Pi/c-Jun NH2-terminal kinase complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

A 2-Cys peroxiredoxin regulates peroxide-induced oxidation and activation of a stress-activated MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Overexpression of antioxidant enzyme peroxiredoxin 5 protects human tendon cells against apoptosis and loss of cellular function during oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Regeneration of peroxiredoxins during recovery after oxidative stress: only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

ATP-dependent reduction of cysteine–sulphinic acid by S. cerevisiae sulphiredoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Reversing the Inactivation of Peroxiredoxins Caused by Cysteine Sulfinic Acid Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Sulfiredoxin: a potential therapeutic agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

The thioredoxin system in retroviral infection and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Does thioredoxin-1 prevent mitochondria- and endoplasmic reticulum-mediated neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Differential expression of peroxiredoxin subtypes in human brain cell types

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Characterization of neural cell types expressing peroxiredoxins in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Peroxiredoxin 2 (PRDX2), an antioxidant enzyme, is under-expressed in Down syndrome fetal brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Analysis of the cytosolic proteome in a cell culture model of familial amyotrophic lateral sclerosis reveals alterations to the proteasome, antioxidant defenses, and nitric oxide synthetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Role of Cdk5-mediated phosphorylation of Prx2 in MPTP toxicity and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Oxidation of a eukaryotic 2-Cys peroxiredoxin is a molecular switch controlling the transcriptional response to increasing levels of hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

Redox control of catalytic activities of membrane-associated protein tyrosine kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M800426200

21 January 2018

Identifiers

DOI

10.1074/JBC.M800426200

1 reference

release_i4jjzscb6rfhhahzv6jxlxsxee

16 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i4jjzscb6rfhhahzv6jxlxsxee

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference